Pompe Disease: Causes Types Symptoms Signs Diagnosis Treatment FAQs
New Enzyme Therapy OK'd for Pompe Disease | MedPage Today
![PDF] Towards a molecular therapy for glycogen storage disease type II (Pompe disease). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/23096233713bb3c15c35b98768f1ecd3d20e276c/4-Figure3-1.png "PDF] Towards a molecular therapy for glycogen storage disease type II (Pompe disease). | Semantic Scholar")
PDF] Towards a molecular therapy for glycogen storage disease type II (Pompe disease). | Semantic Scholar
The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease | PLOS ONE
Pompe Disease: Presentation and Management of Early Onset Type with Perioperative Considerations | Insight Medical Publishing
Pathophysiology of late-onset Pompe disease. Abbreviations: GAA, acid... | Download Scientific Diagram
About Pompe Disease - SaveChloe
Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder
Giant Heart of Classical Infantile-Onset Pompe Disease With Mirror Image Dextrocardia | Circulation: Cardiovascular Imaging
Frontiers | Induced pluripotent stem cell for modeling Pompe disease
Pompe Disease: Presentation and Management of Early Onset Type with Perioperative Considerations | Insight Medical Publishing
Cardiac Pathology: Genetic: Glycogen storage disease Type II (Pompe disease) | Podcasts | Naked Scientists
Glycogen Storage Disease II | Pathology Residency and Fellowship Program | Brown University
Pompe Disease (also called Glycogen storage disease type 2) | CheckRare
Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach | Journal of Cardiovascular Magnetic Resonance | Full Text
Late-onset Pompe disease in a 54 year-old sportsman with an episode of syncope- a case report
JCM | Free Full-Text | The Value of Cardiac Magnetic Resonance Imaging in Identification of Rare Diseases Mimicking Hypertrophic Cardiomyopathy
Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase - ScienceDirect
Non-specificity of symptoms in infantile-onset Pompe disease may delay the diagnosis and institution of treatment | BMJ Case Reports
Therapeutic Benefit of Autophagy Modulation in Pompe Disease: Molecular Therapy
Late-onset Pompe Patients Have Low Heart Disease Risk, Study Finds
Frontiers | Case Report: Identification of Compound Heterozygous Mutations in a Patient With Late-Onset Glycogen Storage Disease Type II (Pompe Disease )
Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe disease | Laboratory Investigation
